Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C10 LIPID MODIFYING AGENTS
C10A LIPID MODIFYING AGENTS, PLAIN
C10AX Other lipid modifying agents
C10AX09 Ezetimibe
D01966 Ezetimibe (JAN/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Cardiovascular Agents
Dyslipidemics, Other
Ezetimibe
D01966 Ezetimibe (JAN/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
218 Hyperlipidemia agents
2189 Others
D01966 Ezetimibe (JAN/USP/INN)
Drug groups [BR:br08330]
Hypolipidemic agent
DG01946 Hypolipidemic agent
D01966 Ezetimibe
Metabolizing enzyme substrate
DG02924 UGT substrate
D01966 Ezetimibe
Transporter substrate
DG02856 SLCO1B1 substrate
D01966 Ezetimibe
DG02965 MRP2 substrate
D01966 Ezetimibe
Drug classes [BR:br08332]
Cardiovascular agent
DG01946 Hypolipidemic agent
D01966 Ezetimibe
Target-based classification of drugs [BR:br08310]
Transporters
Other transporters
Others
NPC1L1
D01966 Ezetimibe (JAN/USP/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D01966
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D01966
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01966
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D01966
Drug transporters
D01966